Articles related to LUNG CANCER

ASCO20 Plenary Sessions

On May 31, 2020, at the virtual scientific program of the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Sessions, late-breaking data dropped for three potentially practice-changing studies: JAVELIN Bladder 100, KEYNOTE-177, and ADAURA.

Hematology June 1st 2020

Tags: LUNG CANCER

FDA Approves Selpercatinib as First Therapy for Certain Patients With Lung, Thyroid Cancers

Based on the results of an open-label trial, selpercatinib (Retevmo) becomes the first targeted therapy to be granted accelerated approval by the FDA for use in patients with cancer who have certain tumors that have an alteration (mutation or fusion) in the RET gene.

Hematology May 18th 2020

Tags: FDA GENE THERAPY LUNG CANCER

<< 1 2 … 14 15

Trending Topics:

Articles related to LUNG CANCER

ASCO20 Plenary Sessions

FDA Approves Selpercatinib as First Therapy for Certain Patients With Lung, Thyroid Cancers

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form